💊 CTCLAV-250 Tablets – Advanced Broad-Spectrum Antibiotic with Superior Cure Rates
CTCLAV-250 Tablets contain Cefuroxime Axetil 250 mg, a powerful second-generation cephalosporin antibiotic designed to treat a wide range of bacterial infections. Known for its enhanced beta-lactamase stability, it is especially effective in eradicating beta-lactamase producing and resistant bacteria, offering superior clinical efficacy and higher cure rates compared to cefixime and amoxicillin-clavulanate.
Backed by strong pharmacological action and broad-spectrum coverage, CTCLAV-250 is trusted by healthcare providers for treating ENT, skin, soft tissue, and bone infections with high safety and efficacy.
🌟 Key Features & Benefits
🛡 Enhanced Beta-Lactamase Stability – Effective even against resistant pathogens
🦠 Broad-Spectrum Antibacterial Coverage – Kills gram-positive and gram-negative organisms
💪 Clinically Superior – Demonstrated greater cure rates than cefixime and amoxicillin-clavulanate
🔄 Effective Against Resistant Strains – Active against cephalothin-, cefamandole-, and gentamicin-resistant bacteria
🏥 Trusted for ENT & Bone Infections – First-line for difficult-to-treat infections
✅ Well-Tolerated – Excellent safety profile in both adults and children
🔬 Pharmacological Activity
Cefuroxime Axetil, a prodrug, is converted in the body to Cefuroxime, which inhibits bacterial cell wall synthesis. This leads to cell lysis and death. It is highly stable in the presence of beta-lactamase enzymes, making it effective where many other antibiotics fail.
🩺 Indications – CTCLAV-250 is Recommended for:
👂 Otitis Media – Effective for ear infections caused by H. influenzae or S. pneumoniae
🗣 Tonsillitis & Pharyngitis – Treats infections from Streptococcus pyogenes
🩹 Skin & Soft Tissue Infections – For infected wounds, abscesses, and cellulitis
🦴 Bone Infections – Reliable choice in osteomyelitis and post-traumatic infections
✔ Eliminates Bacterial Pathogens Effectively, Even Resistant Strains.
📋 Dosage & Administration
| Patient Category | Dosage |
|---|---|
| Adults | 250–500 mg twice daily |
| Children | As directed (usually in suspension form) |
| Administration | Oral, preferably after meals for better absorption |
Always follow the physician’s prescription for optimal results and complete the full antibiotic course.
👤 Ideal for Use In:
Patients with ENT, skin, and musculoskeletal infections
Cases unresponsive to cefixime or amoxicillin-clavulanate
Situations involving drug-resistant bacterial infections
Patients seeking shorter duration and high cure rates
⚠️ Precautions & Warnings
🚫 Avoid in patients allergic to cephalosporins or penicillin
🔄 Adjust dosage in renal impairment
🤰 Use during pregnancy or breastfeeding only under medical supervision
🧾 Complete the full course to avoid bacterial resistance
📦 Product Information
| Brand Name | CTCLAV-250 |
|---|---|
| Composition | Cefuroxime Axetil 250 mg Tablets |
| Form | Oral Tablets |
| Pack Size | Strip of 10 tablets |
| Shelf Life | 24 months from date of manufacture |
| Storage | Store below 25°C, dry and dark place |
🙋♂️ Frequently Asked Questions (FAQs)
❓ What is CTCLAV-250 used for?
CTCLAV-250 is used to treat bacterial infections like otitis media, tonsillitis, pharyngitis, skin infections, and bone infections caused by sensitive organisms.
❓ Is CTCLAV-250 better than cefixime?
Yes. It offers better beta-lactamase resistance and higher clinical cure rates in comparative studies.
❓ Can it treat resistant bacteria?
Yes. It is active against certain cephalothin-, cefamandole-, and gentamicin-resistant bacterial strains.
❓ Can children take CTCLAV-250?
Yes, but the dose should be adjusted and usually administered in suspension form as prescribed by a pediatrician.
❓ Should I take it with food?
Yes. Taking it after meals improves absorption and reduces gastrointestinal discomfort.
❓ What are the possible side effects?
Generally well tolerated. Rarely may cause nausea, diarrhea, or mild skin rash. Consult a doctor if symptoms persist.
user –
completely safe